Please try another search
Arctic Bioscience AS, a clinical-stage biotechnology company, engages in developing and commercializing pharmaceutical and nutraceutical ingredients based on bioactive marine compounds. The company is developing HRO350, a novel oral drug which is in phase IIb for the treatment of mild-to-moderate psoriasis. It also sells nutraceuticals as intermediary and finished goods products under the ROMEGA brand worldwide. The company was incorporated in 2011 and is headquartered in Ørsta, Norway.
Name | Age | Since | Title |
---|---|---|---|
Hu Cao | - | 2021 | Board Member |
Jan Endre Vartdal | 53 | 2015 | Board Member |
Asbjorn Solevagseide | 64 | 2019 | Board Member |
Tore Andreas Froysa Tonseth | 44 | 2021 | Board Member |
Harald Nordal | 66 | 2015 | Co-Founder & Chairman |
Jostein Christian Dalland | 55 | 2020 | Independent Board Member |
Per Magne Eggesbo | 61 | 2016 | Board Member |
Marita Holstad | - | 2021 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review